Epsom, United Kingdom

Alec James Coppen

This inventor holds 1 USPTO granted patent. Top assignee: Scarista Limited. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alec James Coppen. Retrieved from https://idiyas.com/inventor/alec-james-coppen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Depression Treatment by Alec James Coppen

Introduction

Alec James Coppen is a notable inventor based in Epsom, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of depression. His innovative approach combines traditional methods with nutritional supplementation to enhance therapeutic outcomes.

Latest Patents

Coppen holds a patent titled "Treatment of depression and pharmaceutical preparations therefor." This patent outlines a method for improving the efficacy of serotonin reuptake inhibitors (SRIs) and noradrenaline reuptake inhibitors (NRIs) by administering folic acid or its precursors. The recommended daily dosage of folic acid or precursor is designed to provide a folate dosage of 300-5000 micrograms per day, alongside the standard doses of SRIs or NRIs.

Career Highlights

Throughout his career, Alec James Coppen has focused on enhancing mental health treatments. His work has been instrumental in bridging the gap between pharmacological and nutritional therapies. He is associated with Scarista Limited, where he continues to develop innovative solutions for mental health challenges.

Collaborations

[This section has been skipped due to space constraints.]

Conclusion

Alec James Coppen's contributions to the treatment of depression highlight the importance of integrating nutritional elements into pharmaceutical practices. His innovative patent reflects a promising advancement in mental health treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…